Analgesic Solutions is part of WCGclinical.com
If you were trying to reach analgesicsolutions.com, you're in the right place!
As part of our ongoing efforts to simplify and improve our client experience, we have consolidated the WCG Trifecta website to wcgclinical.com.
This does not represent any changes to our service to you, and there are no actions you or your teams need to take at this time.
Below, you’ll find links to our solutions and important resources.
Thank you for the opportunity to support you in your important mission. If you have any questions or concerns, please contact us.
WCG’s Placebo Response Reduction program provides a psychoeducational approach to training monitors, staff and subjects. This encourages neutral expectations from subjects and reduce measurement error, which leads to more successful trials.
Developed from our heritage in measuring pain, our Accurate Symptom Reporting program trains patients to assess and report their symptoms more accurately and consistently. This reduces placebo response, reduces variability, and improves assay sensitivity.
Throughout the course of a trial, our Study Insight Analytics monitor selected metrics that identify statistically significant and clinically relevant aberrant signals in real time. The project team can then swiftly address threats even while the trial is running and blinded.
WCG’s Abuse-Potential Solution (MADDERS®) provides robust identification and assessment of potential abuse-related events as they occur in clinical trials. This allows sponsors and the FDA to more accurately evaluate a drug’s abuse potential in the very patients the medication is designed to treat.
WCG offers comprehensive clinical, cognitive, and functional endpoints and assessments through our network of leading scale authors, test publishers, and copyright holders. We even provide remote administration of assessments for hybrid and decentralized studies.
WCG Imaging is a full-service medical imaging core lab providing comprehensive services to pharmaceutical, biotechnology and medical device companies in support of drug, medical device and artificial intelligence (AI) clinical trials.
Our eCOA/ePRO Platform has substantial benefits for sponsors and CROs, as it reduces administrative burden, mitigates cost, and speeds trials. Such a system shows strong results with fewer errors and discrepancies, improved data quality, clearer signals, and standardized, accurate studies.
Have a question or want to speak with our sales or support teams? Us this form to contact us.
321 Commonwealth Rd.
Wayland, MA 01778